What is the role of botulinum neurotoxin type A in the treatment of chronic bacterial prostatitis (CBP)?

Updated: Jan 15, 2019
  • Author: Samantha D Kraemer, MD; Chief Editor: Edward David Kim, MD, FACS  more...
  • Print
Answer

A double-blind, randomized, placebo-controlled study in 60 consecutive patients with CPPS refractory to medical therapy found that transurethral intraprostatic injection of botulinum neurotoxin type A reduced pain and improved quality of life. By 6 months after treatment, pain had decreased almost 80% from baseline in the treated group. [57]


Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!